Fomepizole

GNF179 is an optimized 8,8-dimethyl imidazolopiperazine analog that exhibits antimalarial potency ( IC 50 of 4.8 nM against the multidrug resistant strain W2). GNF179 is orally activeIn VitroGNF179 does not rapidly inhibit parasite protein

GNF179 is an optimized 8,8-dimethyl imidazolopiperazine analog that exhibits antimalarial potency ( IC 50 of 4.8 nM against the multidrug resistant strain W2). GNF179 is orally activeIn VitroGNF179 does not rapidly inhibit parasite protein

Cell Line Origin Human Caucasian skin fibroblast Gardner&#8242s syndrome Cell Line Description Derived from a 13 year old Caucasian male with Gardner&#8242s syndrome, an autosomal dominant condition which predisposes to carcinoma and multiple

Size: 1 X 96-Well Strip Microplate Kit Target Name(s): FGF-17 Accession Number: O60258 Gene Name(s): FGF17 UNQ161/PRO187 Gene ID: 8822 Species Detected: Human Compatible Sample Types: Cell Culture Supernatants Plasma Serum Sensitivity: 0.25 ng/ml

An isoxazole class pan-BET family inhibitor.

An isoxazole class pan-BET family inhibitor.

An isoxazole class pan-BET family inhibitor.

An isoxazole class pan-BET family inhibitor.

An isoxazole class pan-BET family inhibitor.

ICRF-193 is a bisdiopiperazine derivative. It inhibits topoisomerase II by forming a non-cleavable&nbspcomplex.

ICRF-193 is a bisdiopiperazine derivative. It inhibits topoisomerase II by forming a non-cleavable&nbspcomplex.

A potent, cell-permeable inhibitor of aromatase (IC50 = 2 nM).